RESHMA PUTHOTTU: Open Payments
NPI 1578072500 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 44 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,690 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $188 |
| GENZYME CORPORATION | 4 | $123 |
| Amgen Inc. | 3 | $88 |
| Medimetriks Pharmaceuticals, Inc. | 4 | $87 |
| Galderma Laboratories, L.P. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Organon LLC | 4 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $50 |
| Janssen Biotech, Inc. | 2 | $49 |
| PFIZER INC. | 2 | $45 |
Products named: DUPIXENT, SKYRIZI, OTEZLA, RINVOQ, Rhapsido, Winlevi, TREMFYA, CIBINQO.
Industry payments across VA — which companies pay providers there.
